​Research News

BU lab wasn’t required to clear potentially controversial study with NIH, director says

Original article from STAT by Helen Branswell. October 18, 2022 The director of a Boston University laboratory that conducted potentially controversial research on the viruses that cause Covid-19 said his institution didn’t clear the work with the National Institutes of Health because it wasn’t funded by the federal agency. Ronald Corley said... More

NEIDL Researchers Refute UK Article about COVID Strain

Original article from The Brink by The Brink Staff. October 17, 2022 Boston University is refuting a series of misleading claims about research at the University’s National Emerging Infectious Diseases Laboratories (NEIDL). The reports, which first appeared on Monday in the United Kingdom’s Daily Mail, claimed researchers at the lab had... More

Biochemist Mohsan Saeed Awarded Two Prestigious Federal Grants to Study Viruses

Mohsan Saeed, PhD, assistant professor of biochemistry, has received a five-year, $2 million R35 grant from the National Institute of General Medical Sciences, as well as a five-year, $2.5 million R01 grant from the National Institute of Allergy and Infectious Diseases. It is extremely rare for an early-stage investigator to... More

Draft bill would ban CDC, NIH from funding lab research in China

Original article from Science by Jocelyn Kaiser. June 12, 2022 A proposal moving through Congress to bar the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) from funding research laboratories in China is sparking concern among scientists. If signed into law, the measure could cut off millions... More

TWiV 891: LLOV in the time of Ebola; Interview with Elke Muhlberger & Adam Hume

Original article from This Week in Virology (TWIV) by Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker. April 21, 2022 Elke, Adam, and Gabor join TWiV to discuss their work on Lloviu virus, a filovirus, including recovery of infectious virus from a DNA copy of the genome and from Schreiber’s... More

Research That Matters – NEIDL: Right Place, Right Time

Original article from BU Annual Report. January 31, 2022 Microbiologist Robert Davey’s ongoing novel coronavirus research was boosted with $400,000 through Harvard from the Massachusetts Consortium on Pathogen Readiness, part of $1.6 million in funding that BU researchers received. When news broke that an unknown and dangerous virus had reached US shores... More

BU Scientists Are Prepared to Detect Omicron—and Other Variants

Original article from The Brink By Kat J. McAlpine. December 8, 2021 BU’s National Emerging Infectious Diseases Laboratories (NEIDL) has been monitoring COVID-19 variants from BU and Boston Medical Center tests since February When will the coronavirus variant known as Omicron arrive at BU? Although it’s hard to predict, it seems like... More

Malaria Vaccine—the First Ever to Immunize against a Parasitic Infection—Gets Green Light from WHO (Q&A w/ Davidson Hamer)

Original article from The Brink By Jessica Colarossi. October 7, 2021 Malaria and infectious disease expert says the vaccine could save countless children’s lives in sub-Saharan Africa—but he still has a few concerns In a historic move, the World Health Organization (WHO) on Wednesday announced their recommendation for widespread use of the... More